Le Lézard
Classified in: Health
Subject: SVY

Orchestrate Healthcare Earns Top Integration and Interoperability Consulting Honors, 2018 Black Book Survey


TAMPA, Fla., Aug. 17, 2018 /PRNewswire/ -- Black Book Research announced the top information technology advisors and consultants as collected from nearly 2,000 healthcare providers and organizations in client experience and satisfaction. In total, 142 consultant firms received crowd-sourced evaluations from the polls conducted Q1 to Q3 2018.

Orchestrate Healthcare was rated highest in client experience among competing firms for provider integration, interoperability and connectivity engagement. Orchestrate also ranked among the top advisors for Go-Live Support, EHR Implementations and Clinical Workflow Optimizations.

Black Book Market Research LLC measures customer satisfaction across 20 consultant-centric, copyrighted key performance indicators: level of advisory expertise on subject matter, innovation, training, engagement successes, expertise with governance and organizational structure, strategic engagement customizations, vendor agnostic identification and selection processes, values and integrity, objectivity in advisement, scalability, marginal value adds, client care, accountability and trust, reliability, consultant firm viability and management stability, return on investment, quality of recommendations, process improvement tools, and marketing brand image.

The survey methodology and full listing of healthcare consultant and advisory firm rankings in each category can be found at Black Book's website - https://blackbookmarketresearch.com/it-consultants-and-advisors.

The detailed competitive analysis reports including Orchestrate Healthcare and the independent 2018 State of the Healthcare Technology Advisory and Consultants Industry can be obtained at https://blackbookmarketresearch.com/product-category/2018-Scheduled-Reports.

About Black Book

Black Book Market Research LLC, its founder, management and staff do not own or hold any financial interest in any of the consultants and advisory firms covered and encompassed in the surveys it conducts. Black Book reports the results of the collected satisfaction and client experience rankings in publication and to media before firm notification of rating results and does not solicit survey participation fees, review fees, inclusion or briefing charges, or involve consultant firm collaboration with Black Book before the announcement of the polling outcomes.

In 2009, Black Book began surveying the client experience of healthcare software and managed services users, as well as polling for trend identification, industry insights and outcomes. Black Book expanded its survey prowess and reputation of independent, unbiased crowd-sourced surveying to technology professionals, physician practice administrators, clinicians, user level staff, financial leaders, executives and board members. Consultants and advisor satisfaction polls were first issued in 2011. In 2012, Black Book included payer organizations and insurers, and in 2015, launched panel surveying of healthcare consumers.

For Black Book vendor satisfaction rating methodology, auditing, resources, comprehensive research and ranking data see www.blackbookmarketresearch.com.

Media may request press copies via [email protected].

SOURCE Black Book Market Research LLC


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: